![](https://investorshub.advfn.com/uicon/515354.png?cb=1605015277)
Monday, February 17, 2020 5:47:11 AM
MD&A
The Company is planning the following milestones:
2020
Q1 Submit for ethics in Australia for phase 2 IPF/cough study
Publish research papers IBD & IPF/cough
Q2 Receive ethics approval for phase 2 IPF/cough study
First patient enrolled in phase 2 IPF/cough study
Q4 Possible early data from chronic cough endpoint
2021
Q1 Final data from IPF/cough study
Meanwhile...
/////AMG
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM